Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia

Journal of Clinical Microbiology

Volumn 44, Issue 4, 2006, Pages 1468-1474

  Martínez, Jose A ^a,b   Soto, Sara ^a   Fabrega, Anna ^a   Almela, Manel ^a   Mensa, Josep ^a   Soriano, Alex ^a   Marco, Francesc ^a   Jimenez De Anta, María T ^a   Vila, Jordi ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIAL PERITONITIS; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BIOFILM; BLOOD CULTURE; COMORBIDITY; CORRELATION ANALYSIS; DISEASE COURSE; ESCHERICHIA COLI; FEMALE; GENOTYPE; HIGH RISK POPULATION; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PHYLOGENY; PHYLOGROUP A; PHYLOGROUP B1; PHYLOGROUP B2; PHYLOGROUP D; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE INFECTION; SPECIES DIFFERENCE; STRAIN DIFFERENCE; TIME SERIES ANALYSIS; TREATMENT OUTCOME; URINARY TRACT INFECTION;

AGED; BACTEREMIA; BIOFILMS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; PROGNOSIS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33645952367     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.4.1468-1474.2006     Document Type: Article

References (32)

1. Bingen-Didois, M., O. Clermont, S. Bonacorsi, M. Terki, N. Brahimi, C. Loukil, D. Barraud, and E. Bingen. 2002. Phylogenctic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect. Immun. 70:3216-3226.
2. Blot, F., E. Schmidt, G. Nitenberg, C. Trancrède, B. Leclercq, A. Laplanche, and A. Andremont. 1998. Earlier positivity of central-venous versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J. Clin. Microbiol. 36:105-109.
3. Blot, F., G. Nitenberg, E. Chachaty, B. Raynard, N. Germann, S. Antoun, A. Laplanche, C. Brun-Buisson, and C. Tancrède. 1999. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 354:1071-1077.
4. Clermont, O., S. Bonacorsi, and E. Bingen. 2002. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
5. Dalmau, D., B. Navarro, J. Mirelis, J. Blanco, J. Garau, and G. Prats. 1996. Escherichia coli bacteremia. Serotype O15:K52:H1 as a urinary pathogen. J. Hosp. Infect. 34:233-234.
6. Danese, P. N., L. A. Pratt, S. L. Dove, and R. Kolter. 2000. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol. Microbiol. 37:424-432.
7. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
8. Duriez, P., O. Clermont, S. Bonacorsi, E. Bingen, A. Chaventré, J. Elion, B. Picard, and E. Denamur. 2001. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 147:1671-1676.
9. Gautom, R. K. 1997. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J. Clin. Microbiol. 35:2977-2980.
10. Gransden, W. R., S. J. Eykyn, I. Phillips, and B. Rowe. 1990. Bacteremia due to Escherichia coli: a study of 861 episodes. Rev. Infect. Dis. 12:1008-1018.
11. Hekker, T. A., A. B. Groeneveld, A. M. Simoons-Smit, P. De Man, H. Connell, and D. M. McLaren. 2000. Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteremia. Eur. J. Clin. Microbiol. Infect. Dis. 19:312-316.
12. Javaloyas, M., D. Garcia-Somoza, and F. Gudiol. 2002. Epidemiology and prognosis of bacteremia: a 10-y study in a community hospital. Scand. J. Infect. Dis. 34:436-441.
13. Johnson, J. R., I. Orskov, F. Orskov, P. Goullet, B. Picard, S. L. Moseley, P. L. Roberts, and W. E. Stamm. 1994. O, K, and H antigens predict virulence factors, carboxylesterase B pattern, antimicrobial resistance, and host compromise among Escherichia coli strains causing urosepsis. J. Infect. Dis. 169:119-126.
14. Johnson, J. R., M. A. Kuskowski, T. T. O'Bryan, and J. N. Maslow. 2002. Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia. J. Infect. Dis. 185:1439-1447.
15. Johnson, J. R., M. A. Kuskowski, T. T. O'Bryan, R. Colodner, and R. Raz. 2005. Virulence phenotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob. Agents Chemother. 49:26-31.
16. Johnson, J. R., M. A. Duskowsli, A. Gajewski, D. F. Sahm, and J. A. Karlowsky. 2005. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible isolates of Escherichia coli from across the United States, 2000-2001. J. Infect. Dis. 190:1739-1744.
17. Johnson, J. R., M. A. Kukowski, A. Gajewski, S. Soto, J. P. Horcajada, M. T. Jimenez de Anta, and J. Vila. 2005. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis or prostatitis. J. Infect. Dis. 191:46-50.
18. Khatib, R., K. Riederer, S. Saeed, L. B. Johnson, M. G. Fakih, M. Sharma, M. S. Tabriz, and A. Khosrovaneh. 2005. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin. Infect. Dis. 41:594-598.
19. Kreger, B. E., D. E. Craven, P. H. Carling, and W. E. McCabe. 1980. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am. J. Med. 68:332-343.
20. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
21. Olesen, B., H. J. Kolmos, F. Orskov, I. Orskov, and A. Gottschau. 1995. Bacteremia due to Escherichia coli in a Danish university hospital, 1986-1990. Scand. J. Infect. Dis. 27:253-257.
22. Otto, G., T. Sandberg, B. I. Marklund, P. Ulleryd, and C. Svanborg. 1993. Virulence factors and pap genotype in Escherichia coli isolates from women with acute pyelonephritis, with or without bacteremia. Clin. Infect. Dis. 17:448-456.
23. Prats, G., F. Navarro, B. Mirelis, D. Dalmau, N. Margall, P. Coll, A. Stell, and J. R. Johnson. 2000. Escherichia coli serotype O15:K52:H1 as a uropathogenic clone. J. Clin. Microbiol. 38:201-209.
24. Rupinder, T., T. Ikeda, R. Malaviya, J. I. MacGregor, J. R. Little, S. J. Hultgren, and S. N. Abraham. 1994. The PapG tip adhesin of P fimbriae protects Escherichia coli from neutrophil bactericidal activity. Infect. Immun. 62:5296-5304.
25. Russo, T. A., and J. R. Johnson. 2000. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J. Infect. Dis. 181:1753-1754.
26. Sannes, M. R., M. A. Kuskowski, K. Owens, A. Gajewski, and J. R. Johnson. 2004. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J. Infect. Dis. 190:2121-2128.
27. Vázquez, F., M. C. Mendoza, G. Viejo, and F. J. Méndez. 1992. Survey of Escherichia coli septicemia over a six-year period. Eur. J. Clin. Microbiol. Infect. Dis. 11:110-117.
28. Wang, M. C., C. C. Tseng, C. Y. Chen, J. J. Wu, and J. J. Huang. 2002. The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection. Clin. Infect. Dis. 35:1161-1166.
29. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
30. Wullt, B., G. Bergsten, H. Connell, P. Röllano, N. Gebratsedlk, L. Hang, and C. Svanborg. 2001. P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell. Microbiol. 3:255-264.
31. Xie, Y., K. J. Kim, and K. S. Kim. 2004. Current concepts on Escherichia coli K1 translocation of the blood-brain barrier. FEMS Immunol. Med. Microbiol. 42:271-279.
32. Zhang, K., B. Foxman, and C. Marrs. 2002. Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J. Clin. Microbiol. 40:3951-3955.